After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Xerox Holdings Corp is listed on the NASDAQ as a member of the Technology sector and is a part of the Information Technology Services industry. The current market capitalization of Xerox Holdings Corp is $2.01B. A total of 1.82 million shares were traded on the day, compared to an average of 2.34M shares.
In the most recent transaction, ICAHN CARL C sold 34,245,314 shares of XRX for 15.84 per share on Sep 28 ’23. After the transaction, the 10% Owner now owns 0 company shares. In a previous transaction on Sep 05 ’23, Morno-Wade Suzan sold 9,126 shares at 16.75 per share. XRX shares that EVP & CHRO owns now total 46,323.
Among the insiders who sold shares, BANDROWCZAK STEVEN JOHN disposed of 135,000 shares on Aug 09 ’23 at a per-share price of $15.53. This resulted in the Chief Executive Officer holding 110,557 shares of XRX after the transaction. In another insider transaction, Morno-Wade Suzan sold 5,980 shares at $16.00 per share on Jul 18 ’23. Company shares held by the EVP & CHRO now total 55,449.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, XRX has a high of $19.78 and a low of $12.06.
As of this writing, XRX has an earnings estimate of $Recursion Pharmaceuticals, Inc. per share for the current quarter. EPS was calculated based on a consensus of Lexicon Pharmaceuticals, Inc. estimates, with a high estimate of $Xerox Holdings Corporation per share and a lower estimate of $TRX Gold Corporation.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. XRX’s latest balance sheet shows that the firm has $1.84B in Cash & Short Term Investments as of fiscal 2021. There were $4.54B in debt and $2.83B in liabilities at the time. Its Book Value Per Share was $20.61, while its Total Shareholder’s Equity was $4.45B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XRX is Buy with a score of 1.67.
